 |
Top 10 Prostate cancer treatment startups
Updated: April 19, 2024 |
These startups develop new prostate cancer treatments and diagnostics technologies, such as medical imaging AI, immunotherapy, genome analytics, liquid biopsy.
1
Country: Germany | Funding: $1.7B
We are developing the next generation of personalized immunotherapies to help revolutionize the treatment of people with cancer and other debilitating diseases.
We are developing the next generation of personalized immunotherapies to help revolutionize the treatment of people with cancer and other debilitating diseases.
2
Country: USA | Funding: $925.9M
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
3
Country: UK | Funding: $540M
Myovant Sciences is to deliver innovative women's health (endometriosis treatment) and prostate cancer solutions by efficiently advancing new medicines to market.
Myovant Sciences is to deliver innovative women's health (endometriosis treatment) and prostate cancer solutions by efficiently advancing new medicines to market.
4
Country: Poland | Funding: $377.4M
DEBN is a medical device company developing a novel prostate biopsy needle for urologists which reduces infectious complication rate by delivering the optimal antibiotic combination directly to the prostate, precisely at the place where potential infections start.This augmented prophylaxis could save $2B cost of infections' treatment following 5M biopsies worldwide.
DEBN is a medical device company developing a novel prostate biopsy needle for urologists which reduces infectious complication rate by delivering the optimal antibiotic combination directly to the prostate, precisely at the place where potential infections start.This augmented prophylaxis could save $2B cost of infections' treatment following 5M biopsies worldwide.
5
Country: Canada | Funding: $247.1M
Profound Medical Inc is a medical device company providing Magnetic Resonance guided ablation procedure for prostate care.
Profound Medical Inc is a medical device company providing Magnetic Resonance guided ablation procedure for prostate care.
6
Country: USA | Funding: $220M
Paige.AI, stands for Pathology AI Guidance Engine, is a new startup that uses artificial intelligence to fight cancer. The company focus on breast, prostrate and other major cancers, and expects to partner with other medical centers beyond MSK, as well as commercial labs and pharmaceutical companies as it grows and develops its applications.
Paige.AI, stands for Pathology AI Guidance Engine, is a new startup that uses artificial intelligence to fight cancer. The company focus on breast, prostrate and other major cancers, and expects to partner with other medical centers beyond MSK, as well as commercial labs and pharmaceutical companies as it grows and develops its applications.
7
Country: USA | Funding: $219.5M
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
8
Country: USA | Funding: $110M
Artera offers an AI-enabled test aimed at personalizing therapy for prostate cancer patients
Artera offers an AI-enabled test aimed at personalizing therapy for prostate cancer patients
9
Country: USA | Funding: $95M
Lantern Pharma is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action.
Lantern Pharma is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action.
10
Country: USA | Funding: $90M
Convergent Therapeutics is a pharmaceutical company focused on developing next generation radiopharmaceutical therapies for prostate cancers
Convergent Therapeutics is a pharmaceutical company focused on developing next generation radiopharmaceutical therapies for prostate cancers
Ad
Advertise your startup
11
Country: USA | Funding: $43M
Ezra develops technology for detecting cancer early using MRI & AI. Starting with prostate cancer.
Ezra develops technology for detecting cancer early using MRI & AI. Starting with prostate cancer.
12
Country: USA | Funding: $34.3M
Anixa is a publicly-traded biotechnology company focused on harnessing the body's immune system in the fight against cancer. Anixa's therapeutic portfolio includes a cancer vaccine technology focused on the immunization against α-Lactalbumin to prevent triple negative breast cancer (TNBC), as well as a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology.
Anixa is a publicly-traded biotechnology company focused on harnessing the body's immune system in the fight against cancer. Anixa's therapeutic portfolio includes a cancer vaccine technology focused on the immunization against α-Lactalbumin to prevent triple negative breast cancer (TNBC), as well as a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology.
13
Country: Switzerland | Funding: $21.3M
ProteoMediX is specialized in the identification of novel biomarkers for the early detection of cancer. The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinical standard.
ProteoMediX is specialized in the identification of novel biomarkers for the early detection of cancer. The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinical standard.
14
Country: USA | Funding: $200K
BERG is a biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology platform. This platform combines patient biology and artificial intelligence-based analytics to engage the differences between healthy and disease environments.
BERG is a biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology platform. This platform combines patient biology and artificial intelligence-based analytics to engage the differences between healthy and disease environments.
15
Country: USA | Funding: $19.3M
Image guided laser therapy for prostate cancer in a doctor’s office.
Image guided laser therapy for prostate cancer in a doctor’s office.
16
Country: South Korea | Funding: $17.9M
Deep Bio combines cutting-edge AI algorithms with digital pathology to revolutionize cancer diagnosis. Deep Bio develops AI prostate cancer diagnosis support software
Deep Bio combines cutting-edge AI algorithms with digital pathology to revolutionize cancer diagnosis. Deep Bio develops AI prostate cancer diagnosis support software
17
Country: USA | Funding: $6.9M
Gregor Diagnostics is focusing on the development of an at-home test to screen for prostate cancer, and differentiate between indolent and aggressive forms of the cancer.
Gregor Diagnostics is focusing on the development of an at-home test to screen for prostate cancer, and differentiate between indolent and aggressive forms of the cancer.
18
Country: Finland
Top Data Science is an AI startup that’s developing software that can make sense of millions of data points, alert doctors to unseen medical patterns, help them diagnose disease and track patients during treatment.
Top Data Science is an AI startup that’s developing software that can make sense of millions of data points, alert doctors to unseen medical patterns, help them diagnose disease and track patients during treatment.
19
Country: Canada | Funding: CA$3M
Nanostics is focused on development and commercialization of novel, non-invasive diagnostic tests for cancer.
Nanostics is focused on development and commercialization of novel, non-invasive diagnostic tests for cancer.
20
Country: USA
Dendreon was a biotechnology company produces immunotherapy for prostate cancer. Its cancer vaccine uses a patient’s own immune cells, which are collected, processed and infused back into the individual through an intravenous infusion that is completed in three cycles.
Dendreon was a biotechnology company produces immunotherapy for prostate cancer. Its cancer vaccine uses a patient’s own immune cells, which are collected, processed and infused back into the individual through an intravenous infusion that is completed in three cycles.
21
Country: USA | Funding: $1.5M
Bot Image develops software ProstatID - for post processing MRI using cloud based computing, physician workstation integration, and AI image interpretation to provide highly accurate prostate cancer diagnostics.
Bot Image develops software ProstatID - for post processing MRI using cloud based computing, physician workstation integration, and AI image interpretation to provide highly accurate prostate cancer diagnostics.